RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy
{{output}}
Objective: The primary aim of this study is to investigate the relationship between the expression of the homologous recombination protein RAD51 and the CA125 elimination rate constant K (KELIM) score in the context of sensitivit... ...
